Profile of Critical COVID-19 Illness in Children During the Second and Third Wave of the Pandemic: A Single Center Study from South India

Sangeeta V Budur, S. Thyagarajan
{"title":"Profile of Critical COVID-19 Illness in Children During the Second and Third Wave of the Pandemic: A Single Center Study from South India","authors":"Sangeeta V Budur, S. Thyagarajan","doi":"10.29011/2577-1515.100221","DOIUrl":null,"url":null,"abstract":"Aims : To describe the clinical characteristics of children with critical COVID-19 illness from a single tertiary referral center during the second and third waves to understand the burden of critical COVID-19 illness in children which may guide preparedness in terms of resources, training, and services. Methods: A prospective observational study of critical COVID-19 children under the age of 18 years admitted to a ten-bedded PICU during the second wave (April-July 2021) and third wave (December-February 2022) of the COVID-19 pandemic. We categorized the children into 1) Acute COVID-19 infection and 2) Multi-inflammatory Syndrome in Children - MISC (post COVID-19/MISC secondary to acute COVID-19 infection). Demographic data, clinical data, investigations, treatment given, and outcome measures were studied. Results: Seventy-six critical COVID-19 illness admissions occurred with male preponderance. Sixty-two (81%) children presented with acute COVID-19 illness, 20 in the second wave and 42 in the third wave. Respiratory symptoms (85% vs 30%) predominated during the second wave and neurological symptoms (35% vs 20%) during the third wave. Critical care interventions were higher in the second wave. Neurological comorbidity led to mortality (5% vs 2%). MISC was seen in fourteen (19%) children. Intravenous immunoglobulin and methylprednisolone were given more during the third wave (80% vs 11%). One child in each wave died (11 % vs 20%). Conclusions: The clinical profile of children with critical COVID-19 illness has been changing and becoming progressively complex and atypical during each wave with significant morbidity but with good clinical outcomes/recovery rate.","PeriodicalId":226174,"journal":{"name":"Infectious Diseases Diagnosis & Treatment","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Diseases Diagnosis & Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2577-1515.100221","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims : To describe the clinical characteristics of children with critical COVID-19 illness from a single tertiary referral center during the second and third waves to understand the burden of critical COVID-19 illness in children which may guide preparedness in terms of resources, training, and services. Methods: A prospective observational study of critical COVID-19 children under the age of 18 years admitted to a ten-bedded PICU during the second wave (April-July 2021) and third wave (December-February 2022) of the COVID-19 pandemic. We categorized the children into 1) Acute COVID-19 infection and 2) Multi-inflammatory Syndrome in Children - MISC (post COVID-19/MISC secondary to acute COVID-19 infection). Demographic data, clinical data, investigations, treatment given, and outcome measures were studied. Results: Seventy-six critical COVID-19 illness admissions occurred with male preponderance. Sixty-two (81%) children presented with acute COVID-19 illness, 20 in the second wave and 42 in the third wave. Respiratory symptoms (85% vs 30%) predominated during the second wave and neurological symptoms (35% vs 20%) during the third wave. Critical care interventions were higher in the second wave. Neurological comorbidity led to mortality (5% vs 2%). MISC was seen in fourteen (19%) children. Intravenous immunoglobulin and methylprednisolone were given more during the third wave (80% vs 11%). One child in each wave died (11 % vs 20%). Conclusions: The clinical profile of children with critical COVID-19 illness has been changing and becoming progressively complex and atypical during each wave with significant morbidity but with good clinical outcomes/recovery rate.
第二波和第三波大流行期间儿童COVID-19危重疾病概况:来自南印度的单中心研究
目的:描述某三级转诊中心第二波和第三波COVID-19危重症患儿的临床特征,了解儿童COVID-19危重症的负担情况,为资源、培训和服务准备提供指导。方法:对第二波(2021年4月- 7月)和第三波(2022年12月- 2月)COVID-19大流行期间入住10床PICU的18岁以下重症儿童进行前瞻性观察研究。我们将患儿分为1)急性COVID-19感染和2)儿童多重炎症综合征- MISC(继发于急性COVID-19感染的COVID-19后/MISC)。研究了人口统计资料、临床资料、调查、给予的治疗和结果测量。结果:新冠肺炎危重入院76例,男性居多。62名(81%)儿童出现急性COVID-19疾病,20名出现第二波,42名出现第三波。呼吸道症状(85%对30%)在第二波中占主导地位,神经系统症状(35%对20%)在第三波中占主导地位。第二波重症监护干预较高。神经系统合并症导致死亡(5% vs 2%)。14例(19%)患儿出现MISC。静脉注射免疫球蛋白和甲基强的松龙在第三波给予更多(80%对11%)。每波有一名儿童死亡(11%对20%)。结论:儿童COVID-19危重症的临床特征不断变化,每一波发病均逐渐复杂和非典型,发病率显著,但临床转归/康复率良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信